These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 26508320

  • 21. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
    Sorbe B, Bohr L, Karlsson L, Bermark B.
    Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

  • 25. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
    Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Westerveld H, Haie-Meder C, Petrič P, Mahantshetty U, Dörr W, Pötter R.
    Int J Radiat Oncol Biol Phys; 2014 May 01; 89(1):88-95. PubMed ID: 24725693
    [Abstract] [Full Text] [Related]

  • 26. Radiotherapy of cervical cancer.
    Chargari C, Peignaux K, Escande A, Renard S, Lafond C, Petit A, Lam Cham Kee D, Durdux C, Haie-Méder C.
    Cancer Radiother; 2022 May 01; 26(1-2):298-308. PubMed ID: 34955418
    [Abstract] [Full Text] [Related]

  • 27. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
    Hille A, Weiss E, Hess CF.
    Strahlenther Onkol; 2003 Nov 01; 179(11):742-7. PubMed ID: 14605743
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Preoperative concomitant radiochemotherapy in bulky carcinoma of the cervix: Institut Curie experience].
    Kirova YM, Bourhaleb Z, Alran S, Campitelli M, Plancher C, Fourchotte V, Beuzeboc P, Petrow P, Cottu P, de Cremoux P, Sastre-Garau X, de la Rochefordière A.
    Cancer Radiother; 2009 Jul 01; 13(4):291-7. PubMed ID: 19524469
    [Abstract] [Full Text] [Related]

  • 30. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
    Mazeron R, Castelnau-Marchand P, Dumas I, del Campo ER, Kom LK, Martinetti F, Farha G, Tailleur A, Morice P, Chargari C, Lefkopoulos D, Haie-Meder C.
    Radiother Oncol; 2015 Feb 01; 114(2):257-63. PubMed ID: 25497872
    [Abstract] [Full Text] [Related]

  • 31. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
    Gill BS, Kim H, Houser CJ, Kelley JL, Sukumvanich P, Edwards RP, Comerci JT, Olawaiye AB, Huang M, Courtney-Brooks M, Beriwal S.
    Int J Radiat Oncol Biol Phys; 2015 Mar 01; 91(3):540-7. PubMed ID: 25680598
    [Abstract] [Full Text] [Related]

  • 32. Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: results of a multicenter study.
    Hequet D, Marchand E, Place V, Fourchotte V, De La Rochefordière A, Dridi S, Coutant C, Lecuru F, Bats AS, Koskas M, Bretel JJ, Bricou A, Delpech Y, Barranger E.
    Eur J Surg Oncol; 2013 Dec 01; 39(12):1428-34. PubMed ID: 24183796
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Completion hysterectomy after radiation therapy for bulky cervical cancer stages IB, IIA, and IIB: complications and survival rates.
    Decker MA, Burke JJ, Gallup DG, Silverio RW, Weems D, Duttenhaver J, Purcell D.
    Am J Obstet Gynecol; 2004 Aug 01; 191(2):654-8; discussion 658-60. PubMed ID: 15343258
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival.
    Fanfani F, Vizza E, Landoni F, de Iaco P, Ferrandina G, Corrado G, Gallotta V, Gambacorta MA, Fagotti A, Monterossi G, Perrone AM, Lazzari R, Colangione SP, Scambia G.
    Eur J Surg Oncol; 2016 Oct 01; 42(10):1519-25. PubMed ID: 27241922
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: a Korean Gynecologic Oncology Group study.
    Lee TS, Kang SB, Kim YT, Park BJ, Kim YM, Lee JM, Kim SM, Kim YT, Kim JH, Kim KT.
    Int J Radiat Oncol Biol Phys; 2013 Jun 01; 86(2):304-10. PubMed ID: 23642625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.